ArticleScientific reports2025
A perfusable decellularized plant-based air-liquid-interface-on-a-chip for investigating inorganic dust aerosol exposure.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Plant Cell-on-Chip (PCOC): Exploring the Electrical Modulation Capability of Plant Cells.Micromachines · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Dust exposure affects an estimated 330 million people worldwide and can penetrate deep into the respiratory tract, disrupting epithelial and endothelial barriers. However, current in vitro models do not recapitulate the perfusable airway-vascular interface required to investigate dust-induced barrier alterations. Bioinspired scaffolds from decellularized plants hold strong potential as new approach methodologies (NAMs), considering the need for physiologically relevant in vitro models with vascular networks. Herein, we developed a decellularized plant-based air-liquid interface (ALI)-on-a-chip to study inorganic dust aerosol exposure in human airway epithelial barrier. The decellularization method achieved ≥ 99% DNA removal and a hydrophilic interface, while preserving vascular network and cellulose-rich extracellular matrix. Subsequently, human umbilical vein endothelial cells and bronchial epithelial cells were seeded to the decellularized scaffold, positioned on a PDMS-based platform to reconstruct a perfusable ALI-on-a-chip. Nanoscale dust particles were administered to the epithelium. The dust particles resulted in a significant decrease in barrier integrity, where the TEER value of the epithelial barrier decreased from ~ 126.42 to ~ 56.11Ω*cm
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.